Roivant Sciences
Roivant Sciences Ltd. is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy.
| Company type | Public |
|---|---|
| Nasdaq: ROIV | |
| Industry | Pharmaceuticals |
| Founded | April 7, 2014 |
| Founder | Vivek Ramaswamy |
| Headquarters | Basel, Switzerland |
Key people | Matt Gline (CEO) |
| Revenue | US$61 million (fiscal 2023) |
| −US$1.1 billion (fiscal 2023) | |
| Total assets | US$2.39 billion (fiscal 2023) |
| Total equity | US$1.61 billion (fiscal 2023) |
| Owner | Vivek Ramaswamy (10.5%) |
Number of employees | 904 (fiscal 2023) |
| Website | roivant |
| Footnotes / references | |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.